Why the study?
Does ramipril monotherapy improve biochemical parameters in newly diagnosed essential hypertensive patients?
Population
30 newly diagnosed patients aged 23-70 years with mild to moderate essential hypertension without…
Design
Cohort, open-label
Follow-up
6 months
Authors
Loading...
Metabolic monitoring warranted with antihypertensives; level 5 novel finding leaves open net clinical impact.
Does ramipril monotherapy improve biochemical parameters in newly diagnosed essential hypertensive patients?
Ramipril monotherapy for 6 months in newly diagnosed essential hypertension demonstrates favorable metabolic effects, including improvements in lipid profile, fasting blood sugar, and uric acid levels.
Salve et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: